Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey

Anidulafungin has been shown to be non-inferior to, and possibly more efficacious, than fluconazole in treating patients with invasive candidiasis (IC). This study aimed to determine the cost-effectiveness of anidulafungin vs fluconazole for treatment of IC in the Turkish setting. A decision analyti...

詳細記述

書誌詳細
出版年:Mycoses
第一著者: 2-s2.0-85023160082
フォーマット: 論文
言語:English
出版事項: Blackwell Publishing Ltd 2017
オンライン・アクセス:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023160082&doi=10.1111%2fmyc.12651&partnerID=40&md5=16bbeb143ef3005883e393bae14d20d5